Covered recipient · General Payments record
AMY L AU
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2023–2024
$586.59
- Reported across 12 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $483.45 | 11 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Inari Medical, Inc. | $175.78 | 1 |
| Novo Nordisk AS | $112.00 | 1 |
| Acerta Pharma LLC | $39.43 | 2 |
| Amgen Inc. | $37.29 | 2 |
| ABIOMED | $36.22 | 1 |
| SCPHARMACEUTICALS INC. | $36.15 | 2 |
| BOSTON SCIENTIFIC CORPORATION | $25.03 | 1 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $21.55 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (11)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABIOMED | $36.22 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142206862 | CMS |
| Amgen Inc. | $20.32 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115431529 | CMS |
| Amgen Inc. | $16.97 | 10/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115431534 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.44 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104227103 | CMS |
| AstraZeneca Pharmaceuticals LP | $17.99 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104470760 | CMS |
| Boston Scientific Corporation | $25.03 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092418774 | CMS |
| Inari Medical, Inc. | $175.78 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140178312 | CMS |
| Novartis Pharmaceuticals Corporation | $21.55 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1086780437 | CMS |
| Novo Nordisk Inc | $112.00 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1100624172 | CMS |
| SCPHARMACEUTICALS INC. | $17.46 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132278727 | CMS |
| SCPHARMACEUTICALS INC. | $18.69 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132300342 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.